SAGENT PHARMACEUTICALS INC's ticker is SGNT and the CUSIP is 786692103. A total of 134 filers reported holding SAGENT PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $157,000 | -75.6% | 10,505 | -80.1% | 0.00% | -100.0% |
| Q1 2016 | $644,000 | -23.5% | 52,915 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $842,000 | +61.3% | 52,915 | +55.3% | 0.00% | +100.0% |
| Q3 2015 | $522,000 | -43.2% | 34,078 | -9.8% | 0.00% | -50.0% |
| Q2 2015 | $919,000 | +4.6% | 37,788 | 0.0% | 0.00% | 0.0% |
| Q1 2015 | $879,000 | +146.2% | 37,788 | +165.8% | 0.00% | +100.0% |
| Q4 2014 | $357,000 | -19.2% | 14,215 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $442,000 | +20.1% | 14,215 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $368,000 | +10.8% | 14,215 | 0.0% | 0.00% | 0.0% |
| Q1 2014 | $332,000 | -8.0% | 14,215 | 0.0% | 0.00% | 0.0% |
| Q4 2013 | $361,000 | +24.5% | 14,215 | 0.0% | 0.00% | 0.0% |
| Q3 2013 | $290,000 | -2.7% | 14,215 | 0.0% | 0.00% | 0.0% |
| Q2 2013 | $298,000 | – | 14,215 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vivo Capital, LLC | 6,495,416 | $97,301,000 | 26.57% |
| Stonepine Capital Management, LLC | 356,307 | $5,337,000 | 5.47% |
| Penn Capital Management Company, LLC | 1,841,035 | $27,673,000 | 1.57% |
| SECTORAL ASSET MANAGEMENT INC | 1,008,265 | $15,104,000 | 1.56% |
| Tamarack Advisers, LP | 259,336 | $3,885,000 | 1.49% |
| THB ASSET MANAGEMENT | 632,499 | $9,474,000 | 1.23% |
| JW Asset Management, LLC | 101,630 | $1,522,000 | 1.21% |
| Healthcare Value Capital, LLC | 50,000 | $749,000 | 0.91% |
| Kerrisdale Advisers, LLC | 190,372 | $2,851,000 | 0.77% |
| Healthcare Value Capital, LLC | 35,000 | $524,000 | 0.64% |